Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
-
Schouw & Co. share buy-back programme, week 2 2025
-
Avacta Appoints Brian Hahn as Chief Financial Officer
-
Virtue Recovery Center Champions Harm Reduction in 2025
-
Alpha Omega awarded GSA OASIS+ IDIQ Contract, Expanding Full and Open Vehicle Portfolio
-
Devon Energy Announces Updates to Executive Leadership Team
-
Taylor Morrison to Host Investor Day on March 6, 2025
-
AECOM announces planned dates for first quarter fiscal 2025 earnings results and conference call
-
Alamos Gold Continues to Define High-Grade Mineralization Across the Island Gold Deposit; Ongoing Success Expected to Drive Additional Growth in Mineral Reserves and Resources
-
Vision Marine Technologies Announces $5.8 Million Private Placement
-
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
-
Wallbox’s Quasar 2 Receives U.S. Product Certification from UL Solutions
-
AVPro Global Appoints Loel Wheeler as VP of Sales for Murideo
-
Pharvaris Outlines 2025 Strategic Priorities
-
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook
-
Goliath Drills Remarkable Hole Assaying 34.52 g/t AuEq (1.11 oz/T AuEq) Over 39.00 Meters, Including 132.93 g/t AuEq (4.27 oz/T AuEq) Over 10.00 Meters, Plus Several High-Grade Holes With Multiple Int
-
Ferguson Files Form 8-K
-
Vista Gold Continues to Encounter High Grade Gold Intercepts in Final Holes of 2024 Drilling Program
-
J.Jill, Inc. Reaffirms Fourth Quarter and Full Year 2024 Guidance Ahead of the 27th Annual ICR Conference
-
Amer Sports Announces Preliminary 2024 Financial Results
-
US Foods Reaffirms Fiscal Year 2024 Guidance
-
Lazard Reports December 2024 Assets Under Management
-
Citi Trends Announces 2024 Holiday Sales Results for Quarter-to-Date Through January 4, 2025
-
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2024 Revenue and Adjusted EBITDA Ahead of Guidance and Introduces Fiscal 2025 Revenue and Adjusted EBITDA Guidance
-
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Prices $4.25 Million Public Offering
-
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra
-
Brazil Potash Subsidiary Potássio do Brasil, Signs Preliminary Agreement with Mura Indigenous People for Autazes Potash Project
-
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance
-
AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025
-
Americans for Prosperity Launches $20 Million Campaign to Support the Trump Tax Cuts
-
Fincover®.com Launches Revolutionary Fintech Marketplace for Financial Services
-
Nomad Internet Announced the Unlimited Power Plan, Offering High-Speed Internet, Unlimited Data, and a Free Modem
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
PACS FINAL DEADLINE ALERT: PACS Group (PACS) Investors Alerted to Today’s Lead Plaintiff Deadline in Securities Class Action
-
SuperCom Secures First Agency Contract in Ohio, Rapid U.S Expansion Continues
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Force For Good: Tech Can Catalyze US$15 Trillion Annual Markets Across the World and Solve the UN SDGs
-
Forum Announces Final Assay Results from Tatiggaq; Drill Intercept Identifies Potential New Zone 300 Metres North of the Tatiggaq Deposit
-
Hayasa Metals Announces Results from IP Survey over Vardenis Copper-Gold Project
-
Radisson Provides 2025 Outlook and Exploration & Development Plans for the O'Brien Gold Project
-
Frontage Announces Co-CEO Promotions
-
Southern Cross Gold Consolidated Completes Spin-Out, Consolidation and Name Change, To Commence Trading on the ASX
-
NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
-
SMX Announces Effective Date of Reverse Stock Split
-
Ares Management Corporation Schedules Earnings Release and Conference Call for the Fourth Quarter and Full Year Ending December 31, 2024
-
Jaguar Mining Reports Fourth Quarter and Full Year 2024 Production Results and Provides Outlook for 2025
-
Mosaic and Fosfatados Centro Announce Agreement for Sale of Phosphate Mining Unit in Brazil
-
SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference
-
Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa
-
SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference
